Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Operating Expenses (2020 - 2025)

Journey Medical (DERM) has disclosed Operating Expenses for 6 consecutive years, with $19.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 9.34% year-over-year to $19.2 million, compared with a TTM value of $64.9 million through Sep 2025, down 14.37%, and an annual FY2024 reading of $69.8 million, down 14.08% over the prior year.
  • Operating Expenses was $19.2 million for Q3 2025 at Journey Medical, up from $17.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $32.3 million in Q3 2021 and bottomed at $10.1 million in Q1 2021.
  • Average Operating Expenses over 5 years is $21.3 million, with a median of $21.8 million recorded in 2023.
  • The sharpest move saw Operating Expenses skyrocketed 250.3% in 2021, then plummeted 34.42% in 2024.
  • Year by year, Operating Expenses stood at $26.6 million in 2021, then dropped by 2.31% to $26.0 million in 2022, then plummeted by 33.13% to $17.4 million in 2023, then tumbled by 34.42% to $11.4 million in 2024, then surged by 68.28% to $19.2 million in 2025.
  • Business Quant data shows Operating Expenses for DERM at $19.2 million in Q3 2025, $17.9 million in Q2 2025, and $16.5 million in Q1 2025.